Federal Register / Vol. 75, No. 197 / Wednesday, October 13, 2010 / Notices 62767 

Dated: October 7, 2010. 

Robert W. Bahr, 

Acting Associate Commissioner for Patent 

Examination Policy, United States Patent and 

Trademark Office. 

[FR Doc. 2010–25768 Filed 10–12–10; 8:45 am] 

BILLING CODE 3510–16–P 

DEPARTMENT OF COMMERCE 

United States Patent and Trademark 

Office 

[Docket No. PTO–P–PTO–P–2010–0081] 

Grant of Interim Extension of the Term 

of U.S. Patent No. 4,919,140; AndaraTM

OFSTM System 

AGENCY: United States Patent and 

Trademark Office. 

ACTION: Notice of interim patent term 

extension. 

SUMMARY: The United States Patent and 

Trademark Office has issued an order 

granting interim extension under 35 

U.S.C. 156(d)(5) for a third one-year 

interim extension of the term of U.S. 

Patent No. 4,919,140. 

FOR FURTHER INFORMATION CONTACT: 

Mary C. Till by telephone at (571) 272– 

7755; by mail marked to her attention 

and addressed to the Commissioner for 

Patents, Mail Stop Hatch-Waxman PTE, 

P.O. Box 1450, Alexandria, VA 22313– 

1450; by fax marked to her attention at 

(571) 273–7755, or by e-mail to 

Mary.Till@uspto.gov. 

SUPPLEMENTARY INFORMATION: Section 

156 of Title 35, United States Code, 

generally provides that the term of a 

patent may be extended for a period of 

up to five years if the patent claims a 

product, or a method of making or using 

a product, that has been subject to 

certain defined regulatory review, and 

that the patent may be extended for 

interim periods of up to one year if the 

regulatory review is anticipated to 

extend beyond the expiration date of the 

patent. 

On September 13, 2010, the patent 

owner, Purdue Research Foundation, 

timely filed an application under 35 

U.S.C. 156(d)(5) for a third interim 

extension of the term of U.S. Patent No. 

4,919,140. The patent claims the 

medical device AndaraTM OFSTM

System and a method of using the 

AndaraTM OFSTM System. The 

application indicates that a 

Humanitarian Device Exemption, HDE 

070002, for the medical device 

AndaraTM OFSTM System has been filed 

and is currently undergoing regulatory 

review before the Food and Drug 

Administration for permission to market 

or use the product commercially. 

Review of the application indicates 

that except for permission to market or 

use the product commercially, the 

subject patent would be eligible for an 

extension of the patent term under 35 

U.S.C. 156, and that the patent should 

be extended for an additional one year 

as required by 35 U.S.C. 156(d)(5)(B). 

Because it is apparent that the 

regulatory review period will continue 

beyond the extended expiration date of 

the patent (October 14, 2010), interim 

extension of the patent term under 35 

U.S.C. 156(d)(5) is appropriate. 

A third interim extension under 35 

U.S.C. 156(d)(5) of the term of U.S. 

Patent No. 4,919,140 is granted for a 

period of one year from the extended 

expiration date of the patent, i.e., until 

October 14, 2011. 

Dated: October 7, 2010. 

Robert W. Bahr, 

Acting Associate Commissioner for Patent 

Examination Policy, United States Patent and 

Trademark Office. 

[FR Doc. 2010–25767 Filed 10–12–10; 8:45 am] 

BILLING CODE 3510–16–P 

DEPARTMENT OF DEFENSE 

Office of the Secretary 

[Transmittal Nos. 10–53, 10–54, 10–55, 10– 

59, 10–60, 10–61, and 10–63] 

36(b)(1) Arms Sales Notifications 

AGENCY: Defense Security Cooperation 

Agency, DoD. 

ACTION: Notice. 

SUMMARY: The Department of Defense is 

publishing the unclassified text of seven 

section 36(b)(1) arms sales notifications 

to fulfill the requirements of section 155 

of Public Law 104–164, dated 21 July 

1996. 

FOR FURTHER INFORMATION CONTACT: Ms. 

B. English, DSCA/DBO/CFM, (703) 601– 

3740. 

SUPPLEMENTARY INFORMATION: The 

following are copies of letters to the 

Speaker of the House of Representatives, 

Transmittals 10–53, 10–54, 10–55, 10– 

59, 10–60, 10–61, and 10–63 with 

associated attachments. 

Dated: October 6, 2010. 

Mitchell S. Bryman, 

Alternate OSD Federal Register Liaison 

Officer, Department of Defense. 

Transmittal No. 10–53 

The following is a copy of a letter to 

the Speaker of the House of 

Representatives, Transmittal 10–53 with 

attached transmittal and policy 

justification. 

BILLING CODE 5001–06–P 

mstockstill on DSKH9S0YB1PROD with NOTICES